Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glial cell line-derived neurotrophic factor does not enter normal mouse brain.

Abba J Kastin1, Victoria Akerstrom, Weihong Pan

  • 1VA Medical Center and Tulane University School of Medicine, 1601 Perdido Street, New Orleans, LA 70112-1262, USA. peptides@tulane.edu

Neuroscience Letters
|April 4, 2003
PubMed
Summary

Glial cell line-derived neurotrophic factor (GDNF) does not easily cross the blood-brain barrier (BBB). However, GDNF may be useful for neuroregeneration when delivered peripherally, especially if the BBB is compromised.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype.

Frontiers in psychiatry·2022
Same author

Estrogen can abolish oxytocin-induced spinal anti-hyperalgesia.

Psychoneuroendocrinology·2021
Same author

Phenotypic Resemblance to Neuropsychiatric Disorder and Altered mRNA Profiles in Cortex and Hippocampus Underlying <i>IL15R</i>α Knockout.

Frontiers in neuroscience·2021
Same author

Intracellular interplay between cholecystokinin and leptin signalling for satiety control in rats.

Scientific reports·2020
Same author

Schizophrenia Patient Shows a Rare Interleukin 15 Receptor alpha Variant Disrupting Signal Transduction.

Current molecular medicine·2019
Same author

The Amazon rain forest plant Uncaria tomentosa (cat's claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles.

Scientific reports·2019

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Glial cell line-derived neurotrophic factor (GDNF) shows therapeutic potential for neurodegenerative diseases.
  • Enhancing GDNF's therapeutic efficacy requires understanding its blood-brain barrier (BBB) penetration.
  • Current knowledge on GDNF transport across the BBB is limited.

Purpose of the Study:

  • To investigate the entry of GDNF into the mouse brain.
  • To determine the mechanisms limiting GDNF's BBB permeability.
  • To assess GDNF's potential for peripheral delivery in neuroregeneration.

Main Methods:

  • Utilized multiple-time regression analysis and ex-vivo perfusion to study (125)I-GDNF brain entry.
  • Assessed GDNF integrity using high-performance liquid chromatography.

Related Experiment Videos

  • Measured physicochemical properties like octanol/buffer partition coefficient and hydrogen bonding.

    • Main Results:

    • (125)I-GDNF exhibited very slow brain entry, similar to (99m)Tc-albumin.
    • This limited permeability was not due to degradation, rapid efflux, protein binding, or poor lipophilicity.
    • GDNF demonstrates a unique interaction with the BBB, distinct from other peptides.

    Conclusions:

    • The BBB significantly restricts GDNF entry into the brain in its native form.
    • GDNF's interaction with the BBB is not mediated by typical peptide transport systems.
    • In conditions with a compromised BBB, peripheral GDNF administration could be a viable strategy for neuroregeneration.